< Back to latest news & events

Event

8th Annual Pharma IPR Conference 2019 – Mumbai

March 2019

Event date: 6th March 2019

HGF Partners Martyn Fish and Andy Camenisch will be attending the 8th Annual Pharma IPR Conference 6-8 March in Mumbai.

HGF Partner Andy Camenisch will be sharing insights on “Infringement of Second Medical Use in the EU”.

The Indian Pharma industry has generated astounding growth in the past decades fuelled by increasing burden of disease. In order for the Indian pharmaceutical industry to maximize its true potential, ideation, innovation and integration are pre-requisites to reaching this stupendous growth.

The numerous innovations leading to discovery of new life-saving drugs are through intellectual property rights (IPRs). IPR is a requirement for pharma companies for identification, planning, commercialisation and protection of invention.

The intellectual property market has manifested growth at an unprecedented pace. Risks abound and rights holders need strategic knowledge to maximize their success in the jurisdiction. The Patent Act, 1970 has played a significant role in taking India to the global patent arena.

Attendees

Martyn
Fish

Andrew
Camenisch

Latest updates

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article
Event - 24th - 25th November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Event details

Retailers liability and AI Applications

The question of whether the user (consumer) or the provider of an AI application is liable for the infringement of intellectual property rights as a result of the use of …

Read article
Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
See all updates